Delta 9 Cannabis is now ranked among the top 25 undervalued stocks listed on the Toronto Stock Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below).Medium, small, micro and nano group market capitalization (<10B).
All data provided as-at market close December 08, 2022. The list is sorted by stocks with the greatest percentage difference between valuation and price. Delta 9 Cannabis Delta 9 Cannabis Inc is a Canada-based company engaged in Biotechnology and Medical Research. The company is a licensed producer of medical marijuana and operates a production facility in Winnipeg, Manitoba. Delta 9 Cannabis is listed under DN on the Toronto Stock Exchange.
More about Delta 9 Cannabis
Stocks in this category are held primarily for capital appreciation and/or dividends. The Toronto Stock Exchange (TSX) is the largest exchange in Canada and one of the largest in the world. It is home for “senior” well-established equities.
Artificial intelligence at Report on Business
Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.